Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection. - Fabbiani, M.; Di Giambenedetto, S.; Ragazzoni, E.; Colafigli, M.; Prosperi, M.; Cauda, R.; Navarra, P.; De Luca, A. (HIV Medicine, 2010)